AGP Executive Report
Last update: 7 hours agoBiopharma: GSK plans to start construction in 2027 on its $800 million Upper Merion biologics campus, targeting operations by 2030 and more than 300 permanent jobs. Penn Research: EpiVario secured an option to develop Penn-patented ACSS2 inhibitors for inflammatory bowel disease, an early-stage approach aimed at Crohn’s disease and ulcerative colitis. Agriculture & Health: Penn State and the state Agriculture Department broke ground on an expanded animal diagnostic lab, intended to strengthen disease testing for farms and protect public health. AI in Healthcare: A $21.5 million federal grant backs a new Delaware-based institute involving Penn researchers, who will study AI as a clinical teammate for monitoring symptoms and supporting care decisions. Data-Center Debate: Pennsylvania has launched a map to track data-center plans as communities push back over land use, power demand and local costs. Measles: Pennsylvania’s outbreak has topped 1,100 infections, with a sixth associated death reported in Franklin County.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
